
CAS: 1365888-06-7

2-Propenoic acid, 3-[4-[(1E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)-1-buten-1-yl]phenyl]-, (2E)-
CAS:1365888-06-7
Formula:
C26H20ClFN2O2
Purity:
%
Color and Shape:
Solid
Molecular weight:
446.9006
Ref: IN-DA00123J
5mg | 94.00 € | ||
10mg | 131.00 € |
Estimated delivery in United States, on Monday 10 Mar 2025

Ref: 4Z-B-170001
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Monday 17 Mar 2025

Brilanestrant
CAS:1365888-06-7
Brilanestrant (GDC-0810) is a selective estrogen receptor degrader (IC50: 0.7 nM).
Formula:
C26H20ClFN2O2
Purity:
98.54% - 98.71%
Color and Shape:
Solid Powder
Molecular weight:
446.9
Ref: TM-T5118
1mg | 52.00 € | ||
2mg | 77.00 € | ||
5mg | 106.00 € | ||
10mg | 150.00 € | ||
25mg | 259.00 € | ||
50mg | 427.00 € | ||
100mg | 615.00 € | ||
1mL*10mM (DMSO) | 127.00 € |
Estimated delivery in United States, on Monday 17 Mar 2025

GDC 0810
CAS:1365888-06-7
Estrogen receptor degrader; therapeutic use in breast cancer
Formula:
C26H20ClFN2O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
446.9 g/mol
Ref: 3D-FG137678
5mg | 234.00 € | ||
10mg | 373.00 € | ||
25mg | 586.00 € | ||
50mg | 837.00 € | ||
100mg | 1,313.00 € |
Estimated delivery in United States, on Wednesday 19 Mar 2025